Clinical Decision Support Tools: The Evolution of a Revolution.
about
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation.Personalised dosing of medicines for children.Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.Pharmacometrics-based decision tools facilitate mHealth implementation.Learning Health Systems as Facilitators of Precision Medicine.A New Paradigm. "Learn - Learn More"; Dose-Exposure-Response at the Center of Drug Development and Regulatory Approval.Personalized Drug Dosage - Closing the Loop.Clinical performance of an infliximab rapid quantification assay.Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassaysPrimary care providers' use of pharmacist support for delivery of pharmacogenetic testing.Leveraging Big Data in Pediatric Development Programs: Proceedings From the 2016 American College of Clinical Pharmacology Annual Meeting Symposium.The challenges of implementing pharmacogenomic testing in the clinic.External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation.Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn Disease.Precision Medicine-Nobody Is Average.
P2860
Q38669163-47583A9E-22C8-47AD-8A5F-1F33FFD4E0C9Q38749764-5975FFBB-E183-40EF-99B7-C0CDB492558FQ38759413-6588D343-CC07-45DA-9DC5-4158CF522206Q38998626-2212B75D-34A4-46E7-845C-1A83F662C3D3Q39041482-345BD6D7-C0E4-469C-8D77-D2BCC6552D9FQ39248504-B1E45426-2C52-412E-A744-38A4737B053DQ40956598-73A7A8C4-60A8-4475-BF66-445F6006BF04Q41078459-D071A9AD-6E7F-40C7-835F-2A78FE2609E9Q41078498-6373D03C-F8BF-40B1-92C2-4D926ECE7392Q47428539-836990A7-85FD-4E82-BC29-48EAAC8AC210Q47741125-FEF44852-E6BA-4553-A3C9-3C0973914326Q47929031-48F6C60D-545C-493B-B320-00C5832728EAQ47955297-D369E0A5-A554-4DEE-AC91-1405C27B94E6Q47972996-6EDC3A4B-227B-4043-B3E5-ABFC626CC140Q49171317-A6631C77-963E-4DB5-BA17-849BA004A8B2Q53243386-3CC3512D-5144-4A14-947C-12D2BF15E729Q53508013-B2663371-4E88-4342-9FB8-52BE0351EC8F
P2860
Clinical Decision Support Tools: The Evolution of a Revolution.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Clinical Decision Support Tools: The Evolution of a Revolution.
@en
type
label
Clinical Decision Support Tools: The Evolution of a Revolution.
@en
prefLabel
Clinical Decision Support Tools: The Evolution of a Revolution.
@en
P2093
P2860
P356
P1476
Clinical Decision Support Tools: The Evolution of a Revolution.
@en
P2093
P2860
P304
P356
10.1002/CPT.334
P407
P577
2016-01-19T00:00:00Z